Skip to content

Clinical trials

Completed Acute Coronary Syndrome trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Status: Completed Country / region: China Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20085
20094
20104
20113
20132
20146
20152
20164
20174
20184
20196
20202
20215
20235
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed63

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Harbin Medical University3
Henan Institute of Cardiovascular Epidemiology3
Jiangsu vcare pharmaceutical technology co., LTD3
RenJi Hospital3
Shenyang Northern Hospital3
The First Affiliated Hospital of Dalian Medical University3
Eli Lilly and Company2
Ruttonjee Hospital2
The George Institute for Global Health, China2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome63
Myocardial Ischemia7
Myocardial Infarction6
Cardiovascular Diseases4
Coronary Disease4
Angina, Unstable3
Coronary Artery Disease3
Heart Diseases3
Stroke3
Ischemic Stroke2

Trials

Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.